Literature DB >> 24671951

High-throughput transcription profiling identifies putative epigenetic regulators of hematopoiesis.

Punit Prasad1, Michelle Rönnerblad, Erik Arner, Masayoshi Itoh, Hideya Kawaji, Timo Lassmann, Carsten O Daub, Alistair R R Forrest, Andreas Lennartsson, Karl Ekwall.   

Abstract

Hematopoietic differentiation is governed by a complex regulatory program controlling the generation of different lineages of blood cells from multipotent hematopoietic stem cells. The transcriptional program that dictates hematopoietic cell fate and differentiation requires an epigenetic memory function provided by a network of epigenetic factors regulating DNA methylation, posttranslational histone modifications, and chromatin structure. Aberrant interactions between epigenetic factors and transcription factors cause perturbations in the blood cell differentiation program that result in various types of hematopoietic disorders. To elucidate the contributions of different epigenetic factors in human hematopoiesis, high-throughput cap analysis of gene expression was used to build transcription profiles of 199 epigenetic factors in a wide range of blood cells. Our epigenetic transcriptome analysis revealed cell type- (eg, HELLS and ACTL6A), lineage- (eg, MLL), and/or leukemia- (eg, CHD2, CBX8, and EPC1) specific expression of several epigenetic factors. In addition, we show that several epigenetic factors use alternative transcription start sites in different cell types. This analysis could serve as a resource for the scientific community for further characterization of the role of these epigenetic factors in blood development.

Entities:  

Mesh:

Year:  2014        PMID: 24671951     DOI: 10.1182/blood-2013-02-483537

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Targeting DNA hypermethylation: Computational modeling of DNA demethylation treatment of acute myeloid leukemia.

Authors:  Jens Przybilla; Lydia Hopp; Michael Lübbert; Markus Loeffler; Joerg Galle
Journal:  Epigenetics       Date:  2017-10-06       Impact factor: 4.528

Review 2.  Critical genomic regulation mediated by Enhancer of Polycomb.

Authors:  Naomi E Searle; Lorraine Pillus
Journal:  Curr Genet       Date:  2017-09-07       Impact factor: 3.886

Review 3.  The roles of SNF2/SWI2 nucleosome remodeling enzymes in blood cell differentiation and leukemia.

Authors:  Punit Prasad; Andreas Lennartsson; Karl Ekwall
Journal:  Biomed Res Int       Date:  2015-02-19       Impact factor: 3.411

4.  The NF-κB p65/miR-23a-27a-24 cluster is a target for leukemia treatment.

Authors:  Yong-Chang Zhang; Hui Ye; Zhi Zeng; Y Eugene Chin; Yu-Ning Huang; Guo-Hui Fu
Journal:  Oncotarget       Date:  2015-10-20

Review 5.  Role of HDACs in normal and malignant hematopoiesis.

Authors:  Pan Wang; Zi Wang; Jing Liu
Journal:  Mol Cancer       Date:  2020-01-07       Impact factor: 27.401

6.  The Actin-Family Protein Arp4 Is a Novel Suppressor for the Formation and Functions of Nuclear F-Actin.

Authors:  Shota Yamazaki; Christian Gerhold; Koji Yamamoto; Yuya Ueno; Robert Grosse; Kei Miyamoto; Masahiko Harata
Journal:  Cells       Date:  2020-03-19       Impact factor: 6.600

7.  A regulatory role for CHD2 in myelopoiesis.

Authors:  Farzaneh Shahin Varnoosfaderani; Anna Palau; Wenbo Dong; Jenna Persson; Mickaël Durand-Dubief; J Peter Svensson; Andreas Lennartsson
Journal:  Epigenetics       Date:  2020-01-10       Impact factor: 4.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.